Cancer risk in patients with monoclonal gammopathy of undetermined significance

American Journal of Hematology

Volumn 63, Issue 1, 2000, Pages 1-6

  Gregersen, Henrik ^a   Mellemkjær, Lene ^b   Sailing Ibsen, Jenna ^a   Sørensen, Henrik Toft ^c   Olsen, Jørgen Helge ^b   Pedersen, Jens Oluf ^a   Dahlerup, Jens Frederik ^d  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c UNIVERSITY OF AARHUS   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Lymphoproliferative disorders; Monoclonal gammopathies, benign; Multiple myeloma; Neoplasms; Registries; Waldenstrom's macroglobulinemia

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; CHILD; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; NEWBORN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN M; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASMS; PARAPROTEINEMIAS; RISK FACTORS; WALDENSTROM MACROGLOBULINEMIA;

EID: 0033985764     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M     Document Type: Article

References (19)

1. Kyle RA. Monoclonal gammopathy of undetermined significance (MGUS). Baillière's Clin Haematol 195;8:761-781.
2. Axelsson U, Bachmann R, Hällén J. Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 1966;179:235-247.
3. Saleun JP, Vicariot M, Deroff P, Morin JF. Monoclonal gammopathies in the adult population of Finistère, France. J Clin Pathol 1982;35:63-68.
4. Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, Vives-Corrons JL, Montserrat E. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992;81:391-394.
5. Kyle RA. "Benign" monoclonal gammopathy - After 20 to 35 years of follow-up. Mayo Clin Proc 1993;68:26-36.
6. Colls BM, Lorier MA. Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases. N Z Med J 1975; 82:221-226.
7. Pasqualetti P, Festuccia V, Collacciani A, Casale R. The natural history of monoclonal gammopathy of undetermined significance. Acta Haematol 1997;97:174-179.
8. Williams RC, Bailly RC, Howe RB. Studies of "benign" serum M-components. Am J Med Sci 1969;257:275-293.
9. Solomon A. Homogeneous (monoclonal) immunoglobulins in cancer. Am J Med 1977;63:169-176.
10. Migliore PJ, Alexanian R. Monoclonal gammopathy in human neoplasia. Cancer 1968;21:1127-1131.
11. Kelly RH. Benign monoclonal gammopathy: a reassessment of the problem. Immunol Invest 1985;14:183-197.
12. Johansson BM. Agarose gel electrophoresis. Scand J Clin Lab Invest 1972;291(Suppl 124):7-19.
13. Storm HH. The Danish Cancer Registry, a self-reporting national cancer registration system with elements of active data collection. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG, editors. Cancer registration: principles and methods. Lyon, France: International Agency for Research on Cancer; 1991. p 220-236.
14. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997;44: 549-553.
15. Berry G. The analysis of mortality by the subject-years method. Biometrics 1983;39:173-184.
16. Breslow NE, Day NE. Statistical methods in cancer research. Lyon, France: International Agency for Research on Cancer; 1987. p 65-71.
17. Vuckovic J, Ilic A, Knezevic N, Marinkovic M, Zemunik T. Prognosis in monoclonal gammopathy of undetermined significance. Br J Haematol 1997;97:649-651.
18. Giraldo MP, Rubio-Félix D, Perella M, Garcia JA, Bergua JM, Giralt M. Gammapatías monoclonales de significado indeterminado. Aspectos clínicos, biológicos y evolutivos de 397 casos. Sangre 1991;36: 377-382.
19. Axelsson U. A 20-year follow-up study of 64 subjects with M-components. Acta Med Scand 1986;219:519-522.